Showing 1401-1410 of 18584 results for "".
Issues of Immigration and Healthcare in the United States
https://reachmd.com/programs/focus-on-global-medicine/issues-of-immigration-and-healthcare-in-the-united-states/3967/Over the past several years, immigration and healthcare have become increasingly confounding issues for our nation's lawmakers and policy experts. In many circumstances, like those where a hospital weighs the possibility of transporting a migrant patient back to their country of origin, the two issuMedical Repatriation and Other Migrant Health Issues
https://reachmd.com/programs/focus-on-global-medicine/medical-repatriation-and-other-migrant-health-issues/3965/Lost in the ever-evolving diversity of the American populace, is what happens when one of our newest, or in some cases, undocumented immigrants, becomes extraordinarily ill. Under our current system, hospitals are often left to shoulder the logistical and financial burden of care. How are our hospitRising Health Costs and the Impact on Consumers
https://reachmd.com/programs/clinicians-roundtable/rising-health-costs-and-the-impact-on-consumers/3927/Healthcare costs for family coverage continue to rise. But what are the trends this year faced by US workers? Bianca DiJulio, senior policy analyst for the Health Care Marketplace Project at the Henry J. Kaiser Family Foundation, tells the Chicago Tribune's Bruce Japsen how cost shifts will impact cThrombopoietin & Improved Platlet Disease Management
https://reachmd.com/programs/clinicians-roundtable/thrombopoietin-improved-platlet-disease-management/3711/Platelets have a unique regulatory system in the body that does not respond well to increased or decreased production or destruction. Join guest Dr. David J. Kuter, director of hematology at Massachusetts General Hospital in Boston as he tells host Dr. Bruce Bloom about new findings concerning theNew Drug Therapies for ITP
https://reachmd.com/programs/clinicians-roundtable/new-drug-therapies-for-itp/3710/New drug therapies have just become available for the rare disease Idiopathic Thrombocytopenic Purpura or ITP. Join our guest Dr. David J. Kuter, director of hematology, at Massachusetts General Hospital in Boston to explain the development of romiplostim and other ITP drugs and what clinical impactSurgical Technique To Implant Diaphragm Pacing System
https://reachmd.com/programs/clinicians-roundtable/surgical-technique-to-implant-diaphragm-pacing-system/3614/What is the process required to implant a Diaphragm Pacing System which eliminates the need for ventilator care in ALS patients? Dr. Raymond Onders, director of the Minimally Invasive Surgery at University Hospitals Case Medical Center describes the diagnostic and laparoscopic surgical techniques uImproving Innovation in US Healthcare
https://reachmd.com/programs/focus-on-global-medicine/improving-innovation-in-us-healthcare/3550/Dr. John Kao, author of the recent book Innovation Nation, says that the US spends more on astrology than astronomy, that we suffer from societal anosognosia. He joins host Dr. Leslie Lundt to discuss what other countries are doing to improve innovation in their healthcare and science sectors.Drug Innovations Coming From Outside Big Pharma
https://reachmd.com/programs/clinicians-roundtable/drug-innovations-coming-from-outside-big-pharma/3524/The climate for innovation in the pharmaceutical and biotech industries is fraught with risk, but also holds great potential for reward. Tim Walbert, the chief executive of Horizon Therapeutics, tells host Bruce Japsen about the prospects for growth in life sciences and the biopharmaceutical industrUltrasound: Improving Breast Cancer Detection
https://reachmd.com/programs/advances-in-womens-health/ultrasound-improving-breast-cancer-detection/3514/The number of women affected by breast cancer every year is staggering: almost 180,000 new cases and upwards of 40,000 deaths. Researchers are focused on finding novel ways to detect a malignancy before it spreads-to the lymph nodes and beyond. Dr. Wendie Berg, a breast imaging radiologist associateIndustry Interpretation of Revised PhRMA Code
https://reachmd.com/programs/clinicians-roundtable/industry-interpretation-of-revised-phrma-code/3371/Kristine Rapp, vice president of global ethics & compliance at Hospira, Inc., discusses with host Dr. Maurice Pickard the new PhRMA Code and the significant limitations on gifts to healthcare professionals. The hope is that marketing practices will be held to a higher ethical level.